Hillstream BioPharma, Inc. (HILS) Cash Flow Annual - Discounting Cash Flows
Hillstream BioPharma, Inc.
HILS (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
Report Filing: 2025-05-12 2025-03-26 2024-02-23 2023-03-16 2022-04-01 2020-12-31 2019-12-31
Net Income/Starting Line -11.69 -12.2 -9.32 -8.47 -2.21 -2.42 -1.53
Cash From Operating Activities -10.57 -10.9 -7.3 -6.56 -1.09 -1.08 -0.706
Depreciation and Amortization 0 0 0 1,569 0.667 0 0
Deferred Income Tax 0 0 0 0 -0.667 0 0
Stock Based Compensation 0.46 0.71 0.832 0.801 1.24 0.235 0.092
Other Non-Cash Items 0.324 0 1.23 -1,567 -1.17 0.797 0.485
Changes in Working Capital 0.702 0 -0.046 -0.569 1.05 0.307 0.243
Accounts Receivable 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Accounts Payable 0.069 0.181 -0.046 -0.141 0.85 0.307 -0.03
Deferred Revenue -0.369 0 0.046 -0.428 0.197 0.001 0.273
Other Working Capital 1 -0.181 -0.046 0 0 0 0
Cash From Investing Activities -0 0 0 0 0 0 0
Investments in Property Plant and Equipment -0 0 0 0 0 0 0
Payments for Acquisitions 0 0 0 0 0 0 0
Purchases of Securities 0 0 0 0 0 0 0
Sales and Maturities of Investments 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0
Cash From Financing Activities 1.41 3.53 11.72 13.06 0.899 1.23 0.708
Debt Repayment 0 0 0 0 0 0 0
Common Stock Issued 1.84 4.1 12.23 13.65 0 0 0
Common Stock Repurchased 0 0 0 -0.07 0 0 0
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities 0.004 -0.578 11.72 13.06 0.899 1.23 0.708
Effect of Forex Changes on Cash 0 0 0 0 0 0 0
Net Change in Cash -1.61 -7.38 4.42 6.51 -0.187 0.154 0.002
Cash at Beginning of Period 2.69 10.94 6.51 0.004 0.192 0.038 0.036
Cash at End of Period 1.08 3.56 10.94 6.51 0.004 0.192 0.038
Free Cash Flow -10.57 -10.9 -7.3 -6.56 -1.09 -1.08 -0.706
Operating Cash Flow -10.57 -10.9 -7.3 -6.56 -1.09 -1.08 -0.706
Capital Expenditure -0 0 0 0 0 0 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us